Hospitals Evaluate Diagnostic Kits

The first evaluation data of Biomedical Diagnostics’ LISA TRACKER kits used by three rheumatology centres for the monitoring of patients affected by auto-immune diseases and treated with anti-TNFα, were presented to the 23rd Congress of the French Society of Rheumatology, in Paris during December. This tool allows the clinicians to identify, at various moments of the treatment, a possible resistance with the medicine and to optimise the patients’ management (treatment and followup) over time according to the company.

The hospital centres of La Pitié Salpétrière (Dr Makoto Miyara, Dr Lucile Musset), Bordeaux (Pr Christophe Richez and Pr Patrick Blanco) and Kremlin-Bicêtre / Clamart (Pr Dominique Emilie, Pr Corinne Miceli and Dr Fabien Vincent) implemented the dosages with LISA TRACKER kits and correlated the results to clinical data of some of their patients in rheumatology.

Professor Xavier Mariette, Chief of the Rheumatology Department at the Kremlin-Bicêtre Hospital, mentions the importance of the dosage of these medicines and in this particular case of anti-TNF_, in the monitoring of patients treated by anti-TNF_ in the long term. “It is the topic which is going to become critical in the management of treatments by biological medicines in inflammatory diseases.”

"The biological antibodies took a considerable importance in the treatment of inflammatory diseases. That is why the first results of evaluation of LISA TRACKER kits in hospital centres are particularly encouraging. They demonstrate that the detection of ADAb put in perspective with the dosages of TNF_ and anti- TNF_, can help us to adjust the treatment of the patients in order to make it more effective,” concluded Pr Mariette. Biomedica Diagnostics.